Nour Sabiha Naji

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsHaematological tumoursAutoimmunityMedical anthropology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
A PBD dimer-containing antibody-drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

|Sep 02, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

Nour Sabiha Naji, Taha Ahmedna, J David Peske

|Mar 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.

Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi

|Dec 17, 2024
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.

Nour Sabiha Naji, Mrudula Sathish, Theodoros Karantanos

|Jun 19, 2024
Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.

Priyanka Fernandes, Natalie Waldron, Theodora Chatzilygeroudi

Pageof 1

Frequent Collaborators

4 joint publications

Theodoros Karantanos

1 joint publications

Natalie Waldron

1 joint publications

Yanyan Wang

1 joint publications

Theodora Chatzilygeroudi